Cresemba 186 MG capsule UD 14S
Ended Awarded Last action
- Contract number
- SPE2DR26F9LZ0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,078
Award facts
- Contract value 100% obligated
- $34,077.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $34,077.95 to AmerisourceBergen Drug Corp for Cresemba 186 mg capsule unit dose packs (quantity 14) on January 20, 2026, with completion targeted for January 21, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company being Cencora, Inc. (doing business as AmerisourceBergen). Cresemba is a prescription antifungal medication used to treat serious fungal infections, representing a critical pharmaceutical supply for military healthcare systems.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its significance as a primary pharmaceutical distributor for defense health systems, including the Defense Health Agency and U.S. Coast Guard, with consistent capability to fulfill government contracts for specialized pharmaceutical commodities required across military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F9LZ0?
SPE2DR26F9LZ0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9LZ0 worth?
The government has obligated $34,078 on SPE2DR26F9LZ0.
Is contract SPE2DR26F9LZ0 an order under another contract?
Yes. SPE2DR26F9LZ0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LZ0 competed?
The extent of competition for SPE2DR26F9LZ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award